Cargando…
Presentation, Management and Outcomes of COVID-19 Patients with Sickle Cell Disease
Background Sickle cell disease (SCD) is an inherited disorder of red blood cell (RBC) caused by a mutation in the beta-globin gene resulting in abnormal hemoglobin known as hemoglobin S (HbS) or the sickle hemoglobin. Several clinical variants of SCD have been elucidated, all driven by two fundament...
Autores principales: | Anusim, Nwabundo, Gupta, Ruby, Ahaneku, Hycienth O, Franklin, Candace, Balaraman, Savitha, Huben, Marianne Terese, Jaiyesimi, Ishmael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330372/ http://dx.doi.org/10.1182/blood-2020-138739 |
Ejemplares similares
-
Presentation, management, and outcomes of COVID‐19 in patients with sickle cell disease
por: Anusim, Nwabundo, et al.
Publicado: (2021) -
Hepatobiliary Manifistations of COVID-19 in Sickle Cell Disease: A Case Report
por: Alghamdi, Badria M., et al.
Publicado: (2020) -
Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic
por: De Luna, Gonzalo, et al.
Publicado: (2020) -
Whole Blood Adhesion to VCAM-1 and P-Selectin and RBC Mechanical Fragility Can be Compromised in Long COVID-19 Patients with Sickle Cell Disease
por: Tarasev, Michael, et al.
Publicado: (2021) -
Outcomes of Sickle Cell Disorders in COVID-19 Infection: An Institutional Experience
por: Sewaralthahab, Sarah, et al.
Publicado: (2020)